Moneycontrol

Markets

  • Sensex
    35689.60
    257.21 (0.73%)
  • Nifty
    10821.85
    80.75 (0.75%)
you are here: Moneycontrol Mutual Funds Sector - Pharma & Healthcare SBI Mutual Fund SBI Healthcare Opportunities Fund (G)

SBI Healthcare Opportunities Fund (G)

Previous Name: SBI Pharma Fund - (G)
Plan: Regular | Option: Growth | Type : Open-Ended | AMFI Code: 102823
Fact Sheet Buy
116.380 0.53 ( 0.46 %)
NAV as on 22 Jun, 2018
Crisil MF Rank
Riskometer
HIGH
FUND Family
Success
Alert
Please select a Day.
Info

Not Ranked

The scheme is Not Ranked in Sector - Pharma & Healthcare category by Crisil (for quarter ended Mar 2018 ) from last quarter. If you are already invested in this scheme, you may continue to stay invested. But, do keep a check on its performance.

SBI Pharma Fund has been renamed as SBI Healthcare Opportunities Fund w.e.f. May 16, 2018

Chart

  • Benchmark Index

  • View Historic Graph

Returns (NAV as on Jun 22, 2018)
Period Returns(%) Rank#
1 Month 4.7 8
3 Months -1.6 8
6 Months -11.0 8
1 Year -6.1 8
2 Years -6.0 8
3 Years -5.4 6
5 Years 13.1 4

# Moneycontrol Rank within 12 Sector - Pharma & Healthcare Schemes

*Returns over 1 year are Annualised

* Calculation Remark - Dividends are reinvested at the rate of return

Absolute Returns (in %)
Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2018 -11.2 - - - -
2017 5.7 -9.3 -3.7 9.2 1.5
2016 -11.5 1.9 5.0 -11.2 -14.2
2015 17.3 -3.0 6.4 -0.8 27.0
2014 4.2 14.8 23.7 6.3 56.3
2013 -3.0 9.0 6.4 8.4 25.7

View where it stands within its peers

Return Calculator SIP Calculator

Performance

Fund returns v/s Category average (Large Cap)

* Returns over 1 year are Annualised
  1mth(%) 3mth(%) 6mth(%) 1yr(%) 2yr(%) 3yr(%) 5yr(%)
Fund Returns 4.7 -1.6 -11 -6.1 -6.1 -6 -5.4
Category average 6.6 1.8 -4.5 1.5 -1.2 -1.4 9.8
Difference of Fund returns and Category returns -1.9 -3.4 -6.5 -7.6 -4.9 -4.6 -15.2
Best of Category 8.2 9.2 2.7 15.4 6.9 4.4 16.6
Worst of Category 4.7 -1.6 -11 -6.1 -6 -5.4 11
Benchmark returns # 11.5 7.5 -0.8 1.7 -2 -4.2 0
Difference of Fund returns and Benchmark returns -6.8 -9.1 -10.2 -7.8 -4.1 -1.8 -5.4
# Benchmark Index: S&P BSE HEALTHCARE

Investment Information

Investment Objective

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Registrars
  • Fund Type:

    Open-Ended

  • Investment Plan:

    Growth

  • Launch Date:

    Jan 07, 0999

  • Benchmark:

    S&P BSE HEALTHCARE

  • Asset size (Rs Cr):

    828.41 ( Mar 31, 2018 )

  • Asset Date:

    Mar 31, 2018

  • Minimum Investment:

    Rs.5000

  • Last Dividend:

    N.A. View Dividend History

  • Bonus:

    N.A.

  • Fund Manager:

    Tanmaya Desai
    View performance of schemes managed by the Fund Manager

  • Notes:

    SBI Pharma Fund has been renamed as SBI Healthcare Opportunities Fund w.e.f. May 16, 2018

Load Details
  • Entry Load:

    N.A

  • Exit Load:

    0.50%

  • Load Comments:

    Exit load charge will be 0.50 if redemmed before 15 days 15th july 2016.

Contact Details
peer comparison
Fund Crisil Rank Assets(Rs Cr.) Current NAV 3mth(%) 6mth(%) 1yr(%) 3yr(%) 5yr(%)
Reliance Pharma Fund (G) 1,695.82 145.7 9.0 2.3 14.4 3.4 15.6
Reliance Pharma Fund - Direct Plan (G) 258.39 152.3 9.2 2.7 15.4 4.4 16.6
SBI Healthcare Opportunities Fund (G) 828.41 116.4 -1.6 -11.0 -6.1 -5.4 13.1
SBI Healthcare Opportunities Fund - Direct Plan (G) 218.21 123.6 -1.3 -10.5 -4.9 -4.2 14.3
UTI Healthcare Fund (G) 362.92 84 1.1 -5.9 0.8 -3.1 11.0
*Returns over 1 year are Annualised

Portfolio

Top 10 Holdings As on May 31, 2018
Company Sector Value %Assets
Strides Shasun Pharmaceuticals 62.98 8.87
Sun Pharma Pharmaceuticals 76.86 8.41
Divis Labs Pharmaceuticals 73.32 8.02
Cipla Pharmaceuticals 81.13 6.89
Torrent Pharma Pharmaceuticals 62.11 6.79
Alkem Lab Pharmaceuticals 57.51 6.29
Cadila Health Pharmaceuticals 47.69 5.22
Gufic Bio Pharmaceuticals 44.50 5.17
Aurobindo Pharm Pharmaceuticals 47.30 4.87
Aster DM Health Conglomerates 36.50 3.99
Asset Allocation (%) As on May 31, 2018
Equity 97.55
Others 0.51
Debt 0.00
Mutual Funds 0.00
Money Market 2.43
Cash / Call -0.49
Sector Allocation (%) As on May 31, 2018
Sector %
Pharmaceuticals 87.41
Services 6.15
Conglomerates 3.99
Concentration As on May 31, 2018
Holdings %
Top 5 38.98
Top 10 97.55
Sectors %
Top 3 97.55
Forum | Add a comment...

What`s Your Opinion

Will you invest in a IT-dedicated Mutual Fund scheme?

  • Yes
  • No

Submit

See More

Last Visited
Sections
Follow us on
Available On